Bank of NY Mellon will act as custodian bank to a new cannabis-focused exchange traded fund (ETF), the first time a New York Stock Exchange marijuana-related fund has seen backing by a major bank.
Sectors include biotech, retail and agriculture.
At least 25% of the fund will be invested in pharmaceutical and biotech companies that work in the CBD and other cannabis sectors while there also will be stocks involved in non-plant-touching segments such as real estate.
For more details on the AdvisorShares Pure Cannabis ETF, click here.
What's next for infused products? Manufacturers must cater to demand for CBD, rapid onset and microdosing to stay ahead.